TSE:HBP Helix BioPharma (HBP) Stock Forecast, Price & News C$0.24 0.00 (0.00%) (As of 09/22/2023 ET) Add Compare Share Share Today's RangeC$0.24▼C$0.2450-Day RangeC$0.21▼C$0.2552-Week RangeC$0.19▼C$0.26Volume17,100 shsAverage Volume5,323 shsMarket CapitalizationC$52.00 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsHeadlinesOptions ChainSocial MediaProfileChartCompetitorsEarningsHeadlinesOptions ChainSocial Media About Helix BioPharma (TSE:HBP) StockHelix BioPharma Corp. operates as an immune-oncology company in Canada. The company is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. It has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with University Hospital Tuebingen to assess the therapeutic response of L-DOS47 in cancer models expressing CEACAM6, with advanced preclinical metabolic imaging. The company is headquartered in Toronto, Canada.Read More HBP Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HBP Stock News HeadlinesAugust 22, 2023 | stockhouse.comHelix BioPharma Corp. Announces Closing of Private Placement of CAD $3 Million and Board ChangesJune 14, 2023 | msn.comHelix Biopharma GAAP EPS of -C$0.01September 23, 2023 | Legacy Research (Ad)WARNING: Mandatory U.S. Dollar Recall is Weeks AwayIf you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.June 14, 2023 | finance.yahoo.comHelix BioPharma Corp. Announces Fiscal 2023 Third Quarter ResultsNovember 1, 2022 | proactiveinvestors.comHelix BioPharma advances clinical development of lead candidate L-DOS47, but manages to decrease R&D expenses in 2022 fiscal yearNovember 1, 2022 | finance.yahoo.comHELIX BIOPHARMA CORP. Announces Fiscal 2022 Year-End ResultsSeptember 2, 2022 | proactiveinvestors.comHelix BioPharma Corp names Dr Gabrielle Siegers as its head of research and developmentSeptember 2, 2022 | proactiveinvestors.comHelix BioPharma names Dr Gabrielle Siegers as head of research and developmentSeptember 23, 2023 | Chaikin Analytics (Ad)His system isolated NVIDIA - Here's His Next Buy.Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.September 1, 2022 | finance.yahoo.comHelix Biopharma Corp. Appoints Gabrielle M Siegers as the Head of Research & DevelopmentAugust 30, 2022 | finance.yahoo.comHelix Biopharma Corp. Announces Conclusion of Funding Agreement with Lind Global Macro Fund LPJune 14, 2022 | finance.yahoo.comHELIX BIOPHARMA Corp. Announces Fiscal 2022 Third Quarter ResultsJune 3, 2022 | finance.yahoo.comHelix Biopharma Corp. Announces Closure of Early Warrant Exercise Incentive Program | Raises Aggregate $3.21 MillionMay 17, 2022 | finance.yahoo.comInsiders may be rethinking their CA$3.0m Helix BioPharma Corp. (TSE:HBP) investment now that the company has lost CA$5.0m in valueApril 22, 2022 | finance.yahoo.comJerzy Wilczewski Announces Acquisition of Common Shares of Helix Biopharma Corp.April 18, 2022 | finanznachrichten.deHelix BioPharma Corp.: Helix Biopharma Corp. Announces Appointment of Permanent CEO and Independent Board MembersApril 18, 2022 | finance.yahoo.comHelix Biopharma Corp. Announces Appointment of Permanent CEO and Independent Board MembersApril 7, 2022 | finanznachrichten.deHelix BioPharma Corp.: Helix Announces Board ResignationMarch 22, 2022 | finanznachrichten.deHelix BioPharma Corp.: Helix Biopharma Corp. Announces Management and Board ChangesMarch 22, 2022 | finance.yahoo.comHelix Biopharma Corp. Announces Management and Board ChangesMarch 16, 2022 | finanznachrichten.deHelix BioPharma Corp.: Helix Biopharma Corp. Announces Fiscal 2022 Second Quarter ResultsMarch 16, 2022 | proactiveinvestors.comHelix BioPharma announces sudden passing of interim CEO Slawomir MajewskiMarch 11, 2022 | apnews.comHelix Biopharma Corp. Closes Private Placement and Announces Early Warrant Exercise Incentive Program and Extension of Warrant Exercise PeriodMarch 11, 2022 | finance.yahoo.comCORRECTION: Helix Biopharma Corp. Closes Private Placement and Announces Early Warrant Exercise Incentive Program and Extension of Warrant Exercise PeriodMarch 11, 2022 | finance.yahoo.comHelix Biopharma Corp. Closes Private Placement and Announces Early Warrant Exercise Incentive Program and Extension of Warrant Exercise PeriodDecember 31, 2021 | ca.finance.yahoo.comStocks in play: Helix BioPharma CorpDecember 15, 2021 | finanznachrichten.deHelix BioPharma Corp.: Helix Biopharma Corp. Announces Fiscal 2022 First Quarter ResultsSee More Headlines Receive HBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Helix BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address HBP Company Calendar Today9/23/2023Next Earnings (Estimated)10/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolTSE:HBP CUSIPN/A CIKN/A Webwww.helixbiopharma.com Phone+1-416-9253232FaxN/AEmployees7Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-5,520,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-168.99% Debt Debt-to-Equity Ratio773.67 Current Ratio2.30 Quick Ratio1.04 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares216,670,000Free FloatN/AMarket CapC$52.00 million OptionableOptionable Beta-0.50 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Jacek AntasCEO & DirectorMr. Hatem Kawar M.B.A. (Age 64)MBA, P.Eng, P.Eng., Chief Financial Officer Dr. Gabrielle M. Siegers M.A.Ph.D., Head of R&DMs. Namrata MalhotraCorp. Sec.Key CompetitorsEmerald Health TherapeuticsCVE:EMHProMIS NeurosciencesTSE:PMNSmall PharmaCVE:DMTMicrobix BiosystemsTSE:MBXPediapharmCVE:PDPView All Competitors HBP Stock - Frequently Asked Questions How have HBP shares performed in 2023? Helix BioPharma's stock was trading at C$0.22 at the beginning of the year. Since then, HBP shares have increased by 11.6% and is now trading at C$0.24. View the best growth stocks for 2023 here. When is Helix BioPharma's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, October 30th 2023. View our HBP earnings forecast. What other stocks do shareholders of Helix BioPharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other Helix BioPharma investors own include Lakeland Industries (LAKE), Liquidia (LQDA), Ovintiv (OVV), SIG (SHI), Green Organic Dutchman (TGOD), Zynerba Pharmaceuticals (ZYNE), American Airlines Group (AAL), Aurora Cannabis (ACB), Apollo Investment (AINV) and Aphria (APHA). What is Helix BioPharma's stock symbol? Helix BioPharma trades on the Toronto Stock Exchange (TSX) under the ticker symbol "HBP." How do I buy shares of Helix BioPharma? Shares of HBP stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is Helix BioPharma's stock price today? One share of HBP stock can currently be purchased for approximately C$0.24. How much money does Helix BioPharma make? Helix BioPharma (TSE:HBP) has a market capitalization of C$52.00 million. The biopharmaceutical company earns C$-5,520,000.00 in net income (profit) each year or C($0.02) on an earnings per share basis. How can I contact Helix BioPharma? Helix BioPharma's mailing address is 21 St Clair Ave E Suite 1100, TORONTO, ON M4T 1L9, Canada. The official website for the company is www.helixbiopharma.com. The biopharmaceutical company can be reached via phone at +1-416-9253232. This page (TSE:HBP) was last updated on 9/23/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Helix BioPharma Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.